Key stats
About Huaan CSI Medicine Subdivision Traded Open-end Index Fund
Home page
Inception date
Dec 4, 2013
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
HuaAn Fund Management Co., Ltd.
ISIN
CNE100001QY9
Tightly track the target index, pursue the minimization of tracking deviation and tracking err.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks98.29%
Health Technology95.69%
Retail Trade1.62%
Distribution Services0.98%
Bonds, Cash & Other1.71%
Cash1.71%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
512120 invests in stocks. The fund's major sectors are Health Technology, with 95.69% stocks, and Retail Trade, with 1.62% of the basket. The assets are mostly located in the Asia region.
512120 top holdings are Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A and WuXi AppTec Co., Ltd. Class A, occupying 14.52% and 10.43% of the portfolio correspondingly.
No, 512120 doesn't pay dividends to its holders.
512120 shares are issued by Guotai Junan Securities Co., Ltd. under the brand HuaAn. The ETF was launched on Dec 4, 2013, and its management style is Passive.
512120 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
512120 follows the CSI Subdivided Pharmaceutical Industry Theme Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
512120 invests in stocks.